| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |